Ipsal L Respules 2.5ml
By Ipsal L
Rx
5 Respules in a Packet

Composition
Levosalbutamol(1.25mg) + Ipratropium(500mcg)

Manufacturer - AXA Parenterals Ltd
Axa House, Kishanpur Jamalpur, Roorkee-247667

Expires on or after
September, 2025

liver
Limited information is available regarding the use of Ipsal L Respules 2.5ml in patients with liver impairment. It is essential to consult your doctor if you have any concerns about your liver health. Your doctor will assess the potential risks and benefits before prescribing this medication. No specific interactions with the liver have been established at this time. If you have liver issues, seeking advice from your healthcare provider is crucial to ensure safe use of Ipsal L Respules 2.5ml.

kidney
Limited info on Ipsal L Respules 2.5ml in kidney-impaired patients. Consult doctor regarding concerns. Benefits vs. risks considered before prescribing.

alcohol
Avoid alcohol while taking Ipsal L Respules 2.5ml due to increased drowsiness risk. Combining alcohol with this medication may lead to unwanted side effects or increased alcohol sensitivity.

driving
Duosules-Neo 500/1.25 Respules may lead to blurred vision or dizziness. If these effects occur, refrain from driving.

pregnancy
Ipsal L Respules 2.5ml may be unsafe for use during pregnancy. Animal studies show potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before use. Limited human studies are available on its safety during pregnancy.

breastfeeding
Ipsal L Respules 2.5ml may be safe for breastfeeding, based on limited data. It is advisable to consult a doctor for guidance on its use during breastfeeding. Further research on Duosules-Neo 500/1.25 Respules and breastfeeding is recommended.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹71.35
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024